
Vol. 211, No. 4, 2005
Free Abstract
Article (Fulltext)
Article (PDF 545 KB)
Case Report
Severe Pustular Eruption Associated with Imatinib and Voriconazole in a Patient with Chronic Myeloid Leukemia
E. Gambillaraa, E. Laffittea, N. Widmerb, L.A. Decosterdb, M.A. Duchosalc, T. Kovacsovicsc, R.G. Panizzona
aDermatology, bClinical Pharmacology and cHaematology Services, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Address of Corresponding Author
Dermatology 2005;211:363-365 (DOI: 10.1159/000088510)
Key Words
- Chronic myeloid leukemia
- Imatinib
- Voriconazole
- Cytochrome CYP3A4
Abstract
Imatinib is a specific and potent inhibitor of the BCR-ABL tyrosine kinase. Several clinical trials have demonstrated the efficacy of imatinib in chronic myeloid leukemia. Adverse cutaneous reactions induced by imatinib are frequent and may be dose related. We report a case of an unusual pustular eruption in a patient with chronic myeloid leukemia, who received high doses imatinib for blast crisis and later voriconazole for invasive pulmonary aspergillosis. At the time of his skin eruption, elevated plasma levels of imatinib were recorded. Imatinib is primarily metabolized by the cytochrome CYP3A4. Voriconazole is a cytochrome CYP3A4 inhibitor and can lead to high plasma levels of imatinib. This case suggests that severe drug reactions to imatinib may be related not only to imatinib doses, but also to elevated plasma drug levels resulting from pharmacokinetic interactions. The monitoring of imatinib plasma levels may be of help for identifying patients at risk for severe toxicity. Copyright © 2005 S. Karger AG, Basel
Author Contacts
Emmanuel Laffitte Dermatology Service Centre Hospitalier Universitaire Vaudois CH-1011 Lausanne (Switzerland) Tel. +41 21 314 04 06, Fax +41 21 314 03 92, E-Mail emmanuel.laffitte@chuv.ch
Article Information
Received: August 27, 2004
Accepted: July 1, 2005
Number of Print Pages : 3
Number of Figures : 2, Number of Tables : 0, Number of References : 17 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.
|
|
|